Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
May 3, 2023
Document Date
May 3, 2023
Form Description
Registration of certain classes of securities 12(b) of the Securities Exchange Act
Filing Group
Registration Statements
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/